Recombinant Human Follistatin-like 4 Protein, CF
Recombinant Human Follistatin-like 4 Protein, CF Summary
Product Specifications
Trp23-Val842, with an N-terminal 7-His tag and Asn
Analysis
Product Datasheets
Carrier Free
CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.
In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.
4890-FN
Formulation | Lyophilized from a 0.2 μm filtered solution in PBS. |
Reconstitution | Reconstitute at 300 μg/mL in sterile PBS. |
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage: | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
Reconstitution Calculator
Background: Follistatin-like 4/FSTL4
Follistatin-like 4 (FSTL4) is a presumably secreted member of the follistatin domain-containing protein family (1). Follistatin itself is a potent inhibitor of the TGF-beta superfamily member, activin (1, 2), and this activity is reflected in several other proteins of this family that contain varying numbers of the cysteine-rich follistatin domain. Many of these are matrix proteins such as SPARC and testican for which TGF-beta superfamily inhibition status is presumed but unknown (2, 3). R&D Systems recombinant human FSTL4 inhibits the ability of a TGF-beta superfamily member, BMP-6, to induce osteoblast differentiation of a mouse fibroblast cell line. Human FSTL4 cDNA encodes an 842 amino acid (aa) protein containing a 22 aa signal sequence, a follistatin (EGF- and kazal-like) domain, an EF‑hand calcium-binding motif, and two Ig-like cell adhesion molecule-type (IgCAM) domains (1, 4). The second IgCAM domain contains a consensus sequence for FGF/FGF receptor interaction (4). Mature human FSTL4 shares 84%, 82% and 82% aa identity with mouse, rat and bovine FSTL4, respectively. Identity with other follistatin-like family members is mainly within consensus residues of the follistatin domain. Of two reported human FSTL4 isoforms, one is missing the follistatin and EF‑hand domains, while the other contains all recognized domains, but is truncated after aa 600 (4).
- Glusman, G. et al. (2004) BMC Evol. Biol. 4:43.
- Schneyer, A. et al. (2001) Mol. Cell. Endocrinol. 180:33.
- Hohenester, E. et al. (1997) EMBO J. 16:3778.
- Swissprot Accession # Q6MZW2.
FAQs
No product specific FAQs exist for this product, however you may
View all Proteins and Enzyme FAQsReviews for Recombinant Human Follistatin-like 4 Protein, CF
There are currently no reviews for this product. Be the first to review Recombinant Human Follistatin-like 4 Protein, CF and earn rewards!
Have you used Recombinant Human Follistatin-like 4 Protein, CF?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image